News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Notice
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
Micromet
Phone
Advertisement
31-Jan-2012 | business & finance
All-Cash Transaction Values Micromet at $1.16 Billion
15-Jul-2011 | business & finance
Maximum deal value of EUR 695 million plus royalties and development cost reimbursement
22-Sep-2010 | research and development
Micromet, Inc. announced the initiation of a phase 2 trial of the Company’s lead product candidate blinatumomab (MT103) in adult patients with relapsed or ...
16-Jun-2010 | research and development
Micromet, Inc. announced the presentation of updated results from a Phase 1 trial of the Company's lead product candidate blinatumomab (MT103) in patients ...
10-May-2010 | business & finance
Boehringer Ingelheim and Micromet, Inc. announced that they have entered into a collaboration agreement for the research, development and commercialization ...
11-Dec-2009 | research and development
Micromet, Inc. announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL ...
03-Dec-2009 | business & finance
Micromet, Inc. announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on ...
10-Nov-2009 | business & finance
Micromet, Inc. announced that it has signed an agreement with MedImmune, LLC to buy out MedImmune’s rights to blinatumomab in North America, and to ...
© 1997-2025 LUMITOS AG, All rights reserved
